» Articles » PMID: 35814916

Triglyceride-Glucose Index for the Diagnosis of Metabolic Syndrome: A Cross-Sectional Study of 298,652 Individuals Receiving a Health Check-Up in China

Overview
Publisher Wiley
Specialty Endocrinology
Date 2022 Jul 11
PMID 35814916
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We herein aim to explore the relationship between the triglyceride-glucose (TyG) index and metabolic syndrome (MS).

Methods: We enrolled 298,652 individuals with an average age of 47.08 ± 12.94 years and who underwent health check-ups at the First Affiliated Hospital of Wuhu Wannan Medical College in this cross-sectional study from 2014 to 2016. We enlisted 125,025 women (41.86%) and 173,627 men (58.14%). The survey information included a questionnaire survey, a physical examination, and a laboratory examination.

Results: The prevalence of MS increased gradually in the TyG-index subgroups (1, TyG <8.30; 2, 8.30≤ TyG <8.83; and 3, TyG ≥8.83). We noted significant differences in hypertension, hyperlipidemia, hyperglycemia, sex, age, body mass index (BMI), smoking and drinking habits, and estimated glomerular filtration rate between the TyG-index subgroups. Multiclass logistic regression analysis showed that the group with TyG <8.30 was the reference group, and the 8.30≤ TyG <8.83 and the TyG ≥8.83 groups exhibited a higher TyG index with MS, and a lower TyG index without MS disease. In the linear curve analysis of the TyG index and MS components, BMI, systolic blood pressure, and diastolic blood pressure showed upward trends, while high-density lipoprotein cholesterol showed no obvious trend in the TyG index at a range of 7.8-11.0. Receiver operating characteristic analysis was used to evaluate the predictive value of the TyG index, triglycerides, and fasting blood glucose for MS, and we found that the area under the TyG index curve was the largest (AUC = 0.89).

Conclusion: There were associations between the TyG index and MS and its components, and the TyG index is therefore of great value in the early diagnosis of MS.

Citing Articles

The triglyceride-glucose index is associated with a higher risk of hypertension: evidence from a cross-sectional study of Chinese adults and meta-analysis of epidemiology studies.

Ren X, Chen M, Lian L, Xia H, Chen W, Ge S Front Endocrinol (Lausanne). 2025; 16:1516328.

PMID: 40065994 PMC: 11891255. DOI: 10.3389/fendo.2025.1516328.


Associations of triglyceride glucose-body mass index with short-term mortality in critically ill patients with ischemic stroke.

Ouyang Q, Xu L, Yu M Cardiovasc Diabetol. 2025; 24(1):91.

PMID: 40022139 PMC: 11869470. DOI: 10.1186/s12933-025-02583-1.


Machine Learning-Driven Metabolic Syndrome Prediction: An International Cohort Validation Study.

Li Z, Wu W, Kang H Healthcare (Basel). 2025; 12(24.

PMID: 39765954 PMC: 11675332. DOI: 10.3390/healthcare12242527.


Association between metabolic syndrome and chronic obstructive pulmonary disease development in young individuals: a nationwide cohort study.

Kim O, Lee K, Han K, Cho I, Shin D, Lee S Respir Res. 2024; 25(1):414.

PMID: 39593103 PMC: 11590416. DOI: 10.1186/s12931-024-03038-z.


The mediating effect of TyG and its derived indices in the association between OSAHS and atherosclerosis in patients with T2DM.

Ding L, Jiang X Sleep Breath. 2024; 28(6):2469-2479.

PMID: 39215937 DOI: 10.1007/s11325-024-03081-6.


References
1.
Moghbeli M, Khedmatgozar H, Yadegari M, Avan A, Ferns G, Ghayour Mobarhan M . Cytokines and the immune response in obesity-related disorders. Adv Clin Chem. 2021; 101:135-168. DOI: 10.1016/bs.acc.2020.06.004. View

2.
Baydar O, Kilic A, Okcuoglu J, Apaydin Z, Can M . The Triglyceride-Glucose Index, a Predictor of Insulin Resistance, Is Associated With Subclinical Atherosclerosis. Angiology. 2021; 72(10):994-1000. DOI: 10.1177/00033197211007719. View

3.
Zhang F, Liu L, Zhang C, Ji S, Mei Z, Li T . Association of Metabolic Syndrome and Its Components With Risk of Stroke Recurrence and Mortality: A Meta-analysis. Neurology. 2021; 97(7):e695-e705. DOI: 10.1212/WNL.0000000000012415. View

4.
Feng Y, Fu Y, Xiang Q, Xie L, Yu C, Li J . Plasminogen activator inhibitor-1 gene promoter 4G/5G polymorphism and risks of peripherally inserted central catheter-related venous thrombosis in patients with lung cancer: a prospective cohort study. Support Care Cancer. 2021; 29(11):6431-6439. DOI: 10.1007/s00520-021-06207-8. View

5.
Lin D, Qi Y, Huang C, Wu M, Wang C, Li F . Associations of lipid parameters with insulin resistance and diabetes: A population-based study. Clin Nutr. 2017; 37(4):1423-1429. DOI: 10.1016/j.clnu.2017.06.018. View